Displaying 1 - 10 of 46 results
-
Zero seclusion: Safety and dignity for all – change package | Aukatia te noho punanga: Noho haumanu, tū rangatira mō te tokomaha – mōkī arohaThis Zero seclusion change package | mōkī aroha uses a set of globally recognised, evidence-based interventions aimed at improving the care of tāngata whaiora while moving towards achieving zero seclusion in mental health inpatient units.
-
Mental health and addiction quality improvement programme evaluation 2023An evaluation of the mental health and addiction quality improvement programme, undertaken by social research company Litmus in late 2023.
-
Learning from adverse events and consumer, family and whānau experience (LAECFWE) | Te ako mai i ngā pamamaetanga me to wheako tangata whaiora me to whānauA priority area within the seven-year mental health and addiction (MHA) quality improvement programme coordinated by Te Tāhū Hauora Health Quality & Safety Commission (Te Tāhū Hauora), the LAECFWE project began in September 2019 and ended in 2023.
-
National and technical reports 2022 | Ngā Poutama Oranga Hinengaro: Quality in Context survey of mental health and addiction servicesNational and technical reports 2022 | Ngā Poutama Oranga Hinengaro: Quality in Context survey of mental health and addiction services.
-
Regional reports 2022 | Ngā Poutama Oranga Hinengaro: Quality in Context survey of mental health and addiction servicesThe regional reports for each district health board and non-governmental organisation (summarised by region) from Ngā Poutama Oranga Hinengaro: Quality in Context survey of mental health and addiction services.
-
Presentation: What's happening locallyPresentation by Jacqueline Ryan of our mental health and addiction quality improvement programme from September 2021.
-
Presentations from workshops on project focused on monitoring consumers on particular antipsychotic medication treatment to reduce risk of poor cardiovascular healthSlides are available below from the supra-regional co-design workshops on the project focusing on monitoring consumers on particular antipsychotic medication treatment to reduce risk of poor cardiovascular health.
-
Pono consumer story: Anne-Marie DouglasAnne-Marie Douglas shares her experience of mental health challenges that led to a review process.
-
Pono consumer story: Nicola PeeperkoornNicola Peeperkoorn explores her family’s experience of the mental health and addiction event review process.
-
Pono consumer story: Kolini BakerIn this video Kolini Baker tells the story of her journey with mental ill health and her transition from acute care to community care.